FIELD: organic chemistry, medicine, clinical pharmacology, pharmacy.
SUBSTANCE: invention relates to using a compound chosen from a group consisting of compound of the formula (I) 
and the formula (II) 
, an enantiomer chosen from a group consisting of compounds of the formula (I) and the formula (II), or mixture of enantiomers wherein one of an enantiomer prevails chosen from a group consisting of compounds of the formula (I) and the formula (II) used for manufacturing a pharmaceutical composition used in prophylaxis or treatment of the anxiety disorder. One of enantiomers can prevail in the composition and chosen from a group consisting of compounds of the formula (I) and the formula (II) with their content about 90%, 98% or above. Pharmaceutical compositions are designated for using in broad spectrum of anxiety disorders of different genesis.
EFFECT: valuable medicinal properties of compounds and pharmaceutical composition.
19 cl
| Title | Year | Author | Number |
|---|---|---|---|
| CARBAMATES FOR USING IN PROPHYLAXIS OR TREATMENT OF BIPOLAR DISORDER | 2002 |
|
RU2300372C2 |
| CARBAMATES FOR PREVENTION OR TREATMENT OF BIPOLAR DISORDER | 2002 |
|
RU2286147C2 |
| DERIVATIVES OF CARBAMATES FOR PREVENTING OR TREATING PSYCHOTIC DISORDERS | 2002 |
|
RU2302240C2 |
| METHOD FOR MODELING POST-TRAUMATIC STRESS DISORDER IN LABORATORY RATS | 2020 |
|
RU2746901C1 |
| CARBAMATE DERIVATIVES FOR USING IN PROPHYLAXIS OR TREATMENT IN MOTION DISORDER | 2002 |
|
RU2294739C2 |
| USE OF N,N"-SUBSTITUTED 3,7-DIAZABICYCLO[3_3_1]NONANES DERIVATIVES FOR DEPRESSION THERAPY | 2019 |
|
RU2726313C1 |
| CARBAMATES FOR PROPHYLAXIS OR TREATMENT OF NEURODEGENERATIVE DISORDERS | 2002 |
|
RU2300373C2 |
| CARBAMATE DERIVATIVES USED FOR PAIN TREATMENT | 2002 |
|
RU2283106C2 |
| KETAMINE PAMOATE AND USE THEREOF | 2020 |
|
RU2825336C2 |
| 3,6,9-TRIAZATRICYCLOTETRADECANE DERIVATIVE AND USE THEREOF FOR TREATING DEPRESSION | 2019 |
|
RU2700595C1 |
